
Prateek Bhatia, PhD, discusses barriers to accessing infusion center services and how the pharmacist can alleviate patient challenges.

Prateek Bhatia, PhD, discusses barriers to accessing infusion center services and how the pharmacist can alleviate patient challenges.

McKesson’s Ginger Thorpe discusses the gaps and opportunities in specialty pharmacy’s approach toward care coordination within health systems.

The ASHP Midyear Meeting 2025 showcases pharmacy's evolution, emphasizing teamwork, specialized roles, and innovative strategies to enhance patient care and outcomes.

Pharmacists navigate the evolving landscape of cannabis, balancing patient expectations with emerging evidence on cannabidiol and tetrahydrocannabinol for various medical conditions.

Laura Mark, PharmD, MHM, FASHP, FABC, and Arpit Mehta, PharmD, MPH, MHA, CPEL, FASHP, discuss the immense role automation has shouldered within pharmacy compounding.

Progress against the opioid crisis shows promise, with overdose deaths declining, and pharmacists play a crucial role in life-saving medication strategies.

Explore the complexities of cannabinoids, focusing on cannabidiol and tetrahydrocannabinol, their effects, side effects, and potential drug interactions in modern use.

Pediatric obesity rates surge, prompting a debate on GLP-1 agonists versus traditional treatments, highlighting efficacy, risks, and long-term implications.

Laura Mark, PharmD, MHM, FASHP, FABC, and Arpit Mehta, PharmD, MPH, MHA, CPEL, FASHP, discuss various roles in centralized IV compounding and robotics.

Annie Lambert, PharmD, BCSCP, discusses compliance solutions and the common gaps existing in the pharmacy compounding industry today.

Pharmacists play a vital role in integrating diabetes and depression care, enhancing patient outcomes through screening, individualized treatment, and collaborative approaches.

Lani Bertrand, RPh, discusses Omnicell’s IV compounding solution and how it’s realizing cost savings for pharmacies across the country.

Caitlin Clark shares insights on teamwork and confidence in health care and sports, emphasizing the importance of relationships for success.

Pharmacy technicians evolve into specialized clinical roles, enhancing patient care and reducing turnover.

The evolving landscape of type 2 diabetes management with advanced insulin delivery systems enhances patient outcomes and pharmacist roles.

Misinformation, limited understanding of biosimilars, and inconsistent insurance policies only add to the confusion.

As hospitals and health systems aim to improve outcomes, pharmacists have a large role in managing these conditions with pregnancy-specific therapies.

Key sessions from the National Community Pharmacists Association 2025 Annual Convention & Expo highlight pharmacy benefit manager reform, pneumococcal vaccines, and billable services.

Pharmacy evolves from product-based to holistic care, emphasizing clinical services and patient management, driven by passionate future pharmacists.

Pharmacy professionals gather to discuss innovative solutions, fostering collaboration and community engagement at the National Community Pharmacists Association 2025 Convention & Expo.

Lisa Schwartz, PharmD, discusses her general opinions regarding how the predicted success of the Medicare Drug Price Negotiation Program’s future implementation.

Lisa Schwartz, PharmD, discusses community pharmacies’ displeasure with provisions backing the Medicare Drug Price Negotiation Program.

Lisa Schwartz, PharmD, discusses the importance of the Medicare Transaction Facilitator as community pharmacies head into a new year of the Medicare Drug Price Negotiation Program.

The final part of our interview with Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, focuses on the relationships between state- and federal-level PBM reform.

In part 4 of our interview with Jennifer Griffin, PharmD, MS, she discusses different payer engagement models and the pharmacists’ ability to understand and improve medical billing tactics.

At the NCPA 2025 Annual Convention & Expo, Lucas Morgan, Esq, shareholder with Buchanan Ingersoll & Rooney, joined us to discuss ongoing PBM legislation in the state of Arkansas.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of pharmacy businesses to understand evolving and emerging health care technology.

Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, discusses revenue cycle management and how it has developed within community pharmacy.

Andrew M. Peterson, PharmD, PhD, FCPP, discusses how behavioral health services in community pharmacy help patients receive care impacting all factors of their health and not just medications.

Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, shareholders with Buchanan Ingersoll & Rooney, discuss Utah’s pharmacy benefit manager pass-through rebate law.